Biogen, Inc. (NASDAQ:BIIB)
Q3 2017 Earnings Call
October 24, 2017 8:30 am ET
Executives
Matthew Calistri - Biogen, Inc.
Michel Vounatsos - Biogen, Inc.
Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.
Alfred W. Sandrock, Jr., M.D., Ph.D. - Biogen, Inc.
Paul McKenzie - Biogen, Inc.
Analysts
Umer Raffat - Evercore Group LLC
Geoffrey Meacham - Barclays Capital, Inc.
Eric Schmidt - Cowen and Co. LLC
Ying Huang - Bank of America Merrill Lynch
Cory W. Kasimov - JPMorgan Securities LLC
Geoffrey C. Porges - Leerink Partners LLC
Carter Gould - UBS Securities LLC
Matthew K. Harrison - Morgan Stanley & Co. LLC
Terence Flynn - Goldman Sachs & Co. LLC
Aharon Gal - Sanford C. Bernstein & Co. LLC
Michael J. Yee - Jefferies LLC
Operator
Good morning. My name is Dan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen third quarter 2017 financial results and business update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.
Thank you. I would now like to turn the conference over to Mr. Matt Calistri, Vice President, Investor Relations. You may begin your conference.
